लोड हो रहा है...
Systemic lupus erythematosus and primary fibromyalgia can be distinguished by testing for cell-bound complement activation products
OBJECTIVE: We sought to establish the performance of cell-bound complement activation products (CB-CAPs) as a diagnostic tool to distinguish primary fibromyalgia (FM) from systemic lupus erythematosus (SLE). METHODS: A total of 75 SLE and 75 primary FM adult subjects who fulfilled appropriate classi...
में बचाया:
| में प्रकाशित: | Lupus Sci Med |
|---|---|
| मुख्य लेखकों: | , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
BMJ Publishing Group
2016
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4746498/ https://ncbi.nlm.nih.gov/pubmed/26870391 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/lupus-2015-000127 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|